Silver Andrew Jacob bought CRSP
October 26, 2026 · Form 4 insider transaction
Silver Andrew Jacob bought 9,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,000
Price
$0.00
Total value
N/A
InsiderSilver Andrew Jacob
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after9,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.; This restricted stock unit award was granted on October 26, 2026 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on October 26, 2027, (ii) one quarter of the shares vesting on October 26, 2028, (iii) one quarter of the shares vesting on October 26, 2029, and (iv) one quarter of the shares vesting on October 26, 2030.